Geode Capital Management
FBRX icon

Geode Capital Management’s Forte Biosciences FBRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$829K Buy
64,110
+4,028
+7% +$52.1K ﹤0.01% 3388
2025
Q1
$466K Buy
60,082
+43,205
+256% +$335K ﹤0.01% 3568
2024
Q4
$383K Buy
16,877
+2,607
+18% +$59.2K ﹤0.01% 3691
2024
Q3
$79.9K Sell
14,270
-332,022
-96% -$1.86M ﹤0.01% 4162
2024
Q2
$186K Buy
346,292
+2,860
+0.8% +$1.54K ﹤0.01% 3938
2024
Q1
$241K Buy
343,432
+6,827
+2% +$4.79K ﹤0.01% 3876
2023
Q4
$277K Buy
336,605
+128,222
+62% +$105K ﹤0.01% 3832
2023
Q3
$138K Buy
208,383
+15,050
+8% +$9.97K ﹤0.01% 4135
2023
Q2
$201K Buy
193,333
+143
+0.1% +$149 ﹤0.01% 4038
2023
Q1
$195K Buy
193,190
+742
+0.4% +$749 ﹤0.01% 4066
2022
Q4
$192K Buy
192,448
+1,395
+0.7% +$1.39K ﹤0.01% 4127
2022
Q3
$204K Buy
191,053
+4,455
+2% +$4.76K ﹤0.01% 4202
2022
Q2
$242K Sell
186,598
-70,288
-27% -$91.2K ﹤0.01% 4147
2022
Q1
$375K Buy
256,886
+1,415
+0.6% +$2.07K ﹤0.01% 4084
2021
Q4
$546K Buy
255,471
+154,086
+152% +$329K ﹤0.01% 4000
2021
Q3
$300K Sell
101,385
-77,053
-43% -$228K ﹤0.01% 4268
2021
Q2
$6M Buy
178,438
+90,880
+104% +$3.06M ﹤0.01% 2793
2021
Q1
$3M Buy
87,558
+9,570
+12% +$328K ﹤0.01% 3052
2020
Q4
$2.84M Buy
77,988
+1,515
+2% +$55.2K ﹤0.01% 2892
2020
Q3
$3.71M Buy
76,473
+57,023
+293% +$2.77M ﹤0.01% 2563
2020
Q2
$283K Sell
19,450
-370,055
-95% -$5.38M ﹤0.01% 3561
2020
Q1
$475K Buy
389,505
+60,255
+18% +$73.5K ﹤0.01% 3290
2019
Q4
$175K Buy
329,250
+38,620
+13% +$20.5K ﹤0.01% 3841
2019
Q3
$192K Sell
290,630
-288
-0.1% -$190 ﹤0.01% 3782
2019
Q2
$1.94M Buy
290,918
+21,373
+8% +$143K ﹤0.01% 2974
2019
Q1
$2.93M Buy
269,545
+57,750
+27% +$628K ﹤0.01% 2620
2018
Q4
$1.74M Buy
211,795
+41,261
+24% +$339K ﹤0.01% 2840
2018
Q3
$2.66M Buy
170,534
+68,716
+67% +$1.07M ﹤0.01% 2728
2018
Q2
$950K Buy
101,818
+9,810
+11% +$91.5K ﹤0.01% 3205
2018
Q1
$1.09M Buy
92,008
+1,556
+2% +$18.4K ﹤0.01% 3085
2017
Q4
$927K Buy
90,452
+12,472
+16% +$128K ﹤0.01% 3134
2017
Q3
$971K Buy
77,980
+9,398
+14% +$117K ﹤0.01% 3130
2017
Q2
$825K Buy
+68,582
New +$825K ﹤0.01% 3178